HF
LEXX icon

HRT Financial’s Lexaria Bioscience LEXX Stock Holding History

HRT Financial’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Buy
4,337
+3,106
+252% +$33.7K ﹤0.01% 3841
2026
Q1 		$14K Buy
+1,231
New +$13.4K ﹤0.01% 3605
2024
Q4 		– Sell
-684
Closed -$31K – 2875
2024
Q3 		$31K Buy
+684
New +$32.6K ﹤0.01% 2154

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HRT Financial's LEXX Position: Q2 2026 in Review

HRT Financial increased its Lexaria Bioscience (LEXX) stake by 252% in Q2 2026, buying an estimated $33.7K and bringing the position to 4,337 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

HRT Financial first reported a position in LEXX in Q3 2024 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • HRT Financial held 4,337 shares of Lexaria Bioscience worth $36K as of Q2 2026.
  • HRT Financial bought 3,106 Lexaria Bioscience shares in Q2 2026, an estimated $33.7K.
  • Lexaria Bioscience made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3841 holding.
  • HRT Financial first reported a position in Lexaria Bioscience in Q3 2024 and has held it in 3 quarters since.
  • 29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.